Literature DB >> 27465151

Role of dietary phenols in mitigating microglia-mediated neuroinflammation.

Parakalan Rangarajan1, Aparna Karthikeyan1, S T Dheen2.   

Abstract

Chronic neuroinflammation is a pathological feature of a number of central nervous system (CNS) diseases and is mediated by sustained activation of microglial cells, the innate immune cells of the CNS. Studies have mainly focused on identifying the molecular and epigenetic mechanisms of microglial activation. This is crucial in designing therapeutic strategies for neuropathologies in which prolonged microglial activation is known to exacerbate disease condition. In recent years, increasing evidence show that naturally occurring compounds present in regular diet could function as "nutraceuticals," arresting microglial activation, and thus conferring neuroprotection. This review summarizes our understanding of the role of dietary phenolic nutraceuticals in mitigating microglia-mediated neuroinflammation. Studies show that these natural phenols inhibit key signaling pathways in activated microglia such as the NFκB, MAPK and JAK-STAT that trigger microglia-mediated inflammation in various neuropathological conditions such as injury, infection, stroke, autism and neurodegenerative diseases, i.e., Alzheimer's disease and Parkinson's disease. The anti-inflammatory and antioxidant effect exerted by these natural phenols have shown considerable success in improving disease condition in animal models of neuropathologies, and thus seem to be suitable candidates for developing therapeutic strategies.

Entities:  

Keywords:  CNS; Curcumin; Luteolin; Microglia; Neuroinflammation; Quercetin; Resveratrol

Mesh:

Substances:

Year:  2016        PMID: 27465151     DOI: 10.1007/s12017-016-8430-x

Source DB:  PubMed          Journal:  Neuromolecular Med        ISSN: 1535-1084            Impact factor:   3.843


  126 in total

1.  Stimulation of neurogenesis and synaptogenesis by bilobalide and quercetin via common final pathway in hippocampal neurons.

Authors:  Flaubert Tchantchou; Pascale N Lacor; Zhiming Cao; Lixing Lao; Yan Hou; Changhai Cui; William L Klein; Yuan Luo
Journal:  J Alzheimers Dis       Date:  2009       Impact factor: 4.472

2.  Resveratrol prevents social deficits in animal model of autism induced by valproic acid.

Authors:  Victorio Bambini-Junior; Geancarlo Zanatta; Gustavo Della Flora Nunes; Gabriela Mueller de Melo; Marcus Michels; Mellanie Fontes-Dutra; Valder Nogueira Freire; Rudimar Riesgo; Carmem Gottfried
Journal:  Neurosci Lett       Date:  2014-09-28       Impact factor: 3.046

3.  Utilizing food matrix effects to enhance nutraceutical bioavailability: increase of curcumin bioaccessibility using excipient emulsions.

Authors:  Liqiang Zou; Wei Liu; Chengmei Liu; Hang Xiao; David Julian McClements
Journal:  J Agric Food Chem       Date:  2015-02-13       Impact factor: 5.279

4.  Neuropsychopharmacotherapeutic efficacy of curcumin in experimental paradigm of autism spectrum disorders.

Authors:  Ranjana Bhandari; Anurag Kuhad
Journal:  Life Sci       Date:  2015-09-25       Impact factor: 5.037

5.  Costunolide inhibits proinflammatory cytokines and iNOS in activated murine BV2 microglia.

Authors:  Nirmala Arul Rayan; Nimmi Baby; Daisy Pitchai; Fransisca Indraswari; Eng-Ang Ling; Jia Lu; Thameem Dheen
Journal:  Front Biosci (Elite Ed)       Date:  2011-06-01

6.  Highly stabilized curcumin nanoparticles tested in an in vitro blood-brain barrier model and in Alzheimer's disease Tg2576 mice.

Authors:  Kwok Kin Cheng; Chin Fung Yeung; Shuk Wai Ho; Shing Fung Chow; Albert H L Chow; Larry Baum
Journal:  AAPS J       Date:  2012-12-11       Impact factor: 4.009

7.  Long-term accumulation of microglia with proneurogenic phenotype concomitant with persistent neurogenesis in adult subventricular zone after stroke.

Authors:  Pär Thored; Ursula Heldmann; Walace Gomes-Leal; Ramiro Gisler; Vladimer Darsalia; Jalal Taneera; Jens M Nygren; Sten-Eirik W Jacobsen; Christine T Ekdahl; Zaal Kokaia; Olle Lindvall
Journal:  Glia       Date:  2009-06       Impact factor: 7.452

8.  Mechanisms of microglia-mediated neurotoxicity in a new model of the stroke penumbra.

Authors:  Vikas Kaushal; Lyanne C Schlichter
Journal:  J Neurosci       Date:  2008-02-27       Impact factor: 6.167

Review 9.  Neuroinflammation and M2 microglia: the good, the bad, and the inflamed.

Authors:  Jonathan D Cherry; John A Olschowka; M Kerry O'Banion
Journal:  J Neuroinflammation       Date:  2014-06-03       Impact factor: 8.322

10.  Children with autism spectrum disorders, who improved with a luteolin-containing dietary formulation, show reduced serum levels of TNF and IL-6.

Authors:  I Tsilioni; A Taliou; K Francis; T C Theoharides
Journal:  Transl Psychiatry       Date:  2015-09-29       Impact factor: 6.222

View more
  8 in total

Review 1.  New Assessments and Treatments in ASD.

Authors:  Roula N Choueiri; Andrew W Zimmerman
Journal:  Curr Treat Options Neurol       Date:  2017-02       Impact factor: 3.598

2.  Walnut-Associated Fatty Acids Inhibit LPS-Induced Activation of BV-2 Microglia.

Authors:  Amanda N Carey; Derek R Fisher; Donna F Bielinski; Danielle S Cahoon; Barbara Shukitt-Hale
Journal:  Inflammation       Date:  2020-02       Impact factor: 4.092

Review 3.  Sequestration of Inflammation in Parkinson's Disease via Stem Cell Therapy.

Authors:  Jonah Gordon; Gavin Lockard; Molly Monsour; Adam Alayli; Hassan Choudhary; Cesario V Borlongan
Journal:  Int J Mol Sci       Date:  2022-09-04       Impact factor: 6.208

Review 4.  Oxidative stress-mediated beta cell death and dysfunction as a target for diabetes management.

Authors:  Svetlana Dinić; Jelena Arambašić Jovanović; Aleksandra Uskoković; Mirjana Mihailović; Nevena Grdović; Anja Tolić; Jovana Rajić; Marija Đorđević; Melita Vidaković
Journal:  Front Endocrinol (Lausanne)       Date:  2022-09-23       Impact factor: 6.055

5.  Effects of ganoderic acid A on lipopolysaccharide-induced proinflammatory cytokine release from primary mouse microglia cultures.

Authors:  Baojin Chi; Shuqiu Wang; Sheng Bi; Wenbo Qin; Dongmei Wu; Zhenguo Luo; Shiliang Gui; Dongwei Wang; Xingzhong Yin; Fangfang Wang
Journal:  Exp Ther Med       Date:  2017-11-08       Impact factor: 2.447

6.  Polyphenols journey through blood-brain barrier towards neuronal protection.

Authors:  I Figueira; G Garcia; R C Pimpão; A P Terrasso; I Costa; A F Almeida; L Tavares; T F Pais; P Pinto; M R Ventura; A Filipe; G J McDougall; D Stewart; K S Kim; I Palmela; D Brites; M A Brito; C Brito; C N Santos
Journal:  Sci Rep       Date:  2017-09-13       Impact factor: 4.379

7.  Paving Plant-Food-Derived Bioactives as Effective Therapeutic Agents in Autism Spectrum Disorder.

Authors:  Natália Cruz-Martins; Cristina Quispe; Celale Kırkın; Ezgi Şenol; Aslı Zuluğ; Beraat Özçelik; Adedayo O Ademiluyi; Olubukola Helen Oyeniran; Prabhakar Semwal; Manoj Kumar; Farukh Sharopov; Victor López; Francisco Les; Iulia-Cristina Bagiu; Monica Butnariu; Javad Sharifi-Rad; Mohammed M Alshehri; William C Cho
Journal:  Oxid Med Cell Longev       Date:  2021-08-21       Impact factor: 6.543

Review 8.  Lifestyle-dependent microglial plasticity: training the brain guardians.

Authors:  Marcus Augusto-Oliveira; Alexei Verkhratsky
Journal:  Biol Direct       Date:  2021-08-05       Impact factor: 4.540

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.